Hubei Hongyuan Pharmaceutical Technology Co Ltd Sustainability Reports
The company engages in the research, development, production, and sale of organic chemical raw materials, pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and pharmaceutical preparations. It also produces new energy materials such as lithium hexafluorophosphate.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001V3K3T6
1 reports from 2024 to 2024
